The three-dimensional structure of a catalytic antibody, 6D9, has been solved as a complex with a transition state analog. The structure was determined from two different crystal forms, and was re®ned at a resolution of 1.8 A Ê . The antibody 6D9, which was induced by immunization with the phosphonate transition state analog 3, hydrolyzes a prodrug of chloramphenicol monoester 1 to generate the parent drug 2. The kinetic studies have shown that the antibody is catalytic by virtue of the theoretical relationship between the af®nity for the transition state and the catalytic ef®ciency (k cat /k uncat K S /K TSA ). The crystal structure makes it possible to visualize the theoretical relationship. A side-chain (N e ) of His L27D is placed in a key position to make a hydrogen bond to the phosphonate oxygen of the transition state analog with a distance of 2.72 A Ê , suggesting a hydrogen bond to the oxyanion developing in the transition state of the hydrolysis. There are no catalytic residues, other than the histidine, around the phosphonate moiety. In addition, in the antibody-hapten complex, the hapten bears a folded conformation and the two stacked aromatic rings are buried deep in the antigen-combining site through aromatic-aromatic interaction with Trp H100I and Tyr
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. The conformation of the bound hapten suggests that the antibody binds the substrate to change the conformation of the ester moiety to a thermodynamically unstable E-form, thereby making it easy for the substrate to reach the transition-state during catalysis. These observations reveal that the catalytic mechanism is explained purely on the basis of the stabilization of the transition state. The re®ned high resolution structures reported here are envisaged to have an impact on the understanding of other hydrolytic antibodies, since their haptens share some unique features with the hapten used in this study.
Introduction
Since the mammalian immune system is characterized by an almost limitless potential for providing receptor-like molecules for virtually any chemical structure, catalytic antibodies can provide the tailor-made catalysts for reactions, in which no natural counterpart exists (Schultz & Lerner, 1995; Lerner & Schultz, 1993; Lerner et al., 1991; Shokat & Schultz, 1990; Tramontano et al., 1986) . Such antibodies have been generated against the putative transition state analogs (TSA), with the expec-tation that the induced antigen-combining site could be both geometrically and electronically complementary to the transition state for the reactions, and might stabilize this species through a variety of enthalpic or entropic contributions. Therefore, for catalytic antibody research, it is important to understand the relationship between the chemical properties of the TSAs and the catalytic functions of the induced antibodies. The theoretical relationship has been evaluated by correlating the catalytic activity of an antibody and the differential binding of the TSA and the substrate Stewart & Benkovic, 1995) . If antibodies are catalytic by virtue of the theoretical relationship between the af®nity for the transition state and the catalytic ef®ciency, the ratio of the dissociation constants for the transition state analog (K TSA ) and the corresponding substrate (K S ) should be equal to the rate enhancement (k cat / k uncat K S /K TSA ). To visualize this concept, here, we have determined the crystal structures of the Fab fragment of antibody 6D9 in complex with a transition state analog.
Catalytic antibody 6D9, which was induced by immunization with the haptenic phosphonate 3, catalyzes the hydrolysis of a non-bioactive chloramphenicol monoester derivative 1 to generate chloramphenicol 2, as shown in Figure 1 (Miyashita et al., 1993) . Among the large number of hydrolytic catalytic antibodies, of which a few have been examined to de®ne the three-dimensional structures by X-ray crystallography (Wedemayer et al., 1997; Charbonnier et al., 1995 Charbonnier et al., , 1997 Patten et al., 1996; Zhou et. al., 1994) , catalytic antibody 6D9 is characterized as an antibody that functions strictly according to the theoretical relationship described above. Thus, the rate enhancement (k cat /k uncat 895) observed with 6D9 is in close agreement with the ratio (K S / K TSA 900) of the binding af®nities to the transition-state analog and the substrate. This suggests a reaction mechanism in which the antibody-hapten binding interactions are also present in the transition-state and serve to accelerate the reaction rate. Thus, the antibody 6D9 should provide a suitable system to analyze the correlation among transition state analogs, active site structures, and catalytic functions. In addition, the extensive data characterizing the catalytic activity of 6D9, obtained by kinetic, mutation, and chemical modi®cation studies can be used to discuss the catalytic structure (Miyashita et al., 1997; Fujii et al., 1995) .
Here, we report crystal structures of the Fab 6D9 complexed with a phosphonate derivative 4. Although we attempted to crystallize the Fab fragment as a complex with both the original hapten 3 and its derivatve 4, only the complex with 4 enabled us to determine the crystal structure at high resolution: The additional atoms incorporated into derivative 4 seem to ®ll a void in the crystal lattice to bene®cially affect the crystal packing. Our results showed that the structual modi®cation, introduced at the phosphonate moiety, extends as an appendage into the solvent region, and thus is not involved in the antibody-ligand binding interaction. This is supported by an evidence that the derivative 4 displayed a dissociation constant (K d ) and an inhibition constant (K i ) practically identical to those of immunized hapten 3. Thus, these observations allowed us to discuss the mechanistic interpretation of the antibody-catalyzed reaction in relation to the X-ray structures. The crystal structures of the Fab 6D9 with a putative transition state analog bound at the active site, reported here, provide a detailed description of the combining site environment, and lend support to a simple catalytic mechanism, involving only the attributes of transition state stabilization.
Results

Quality of the structures
The two crystal structures of the Fab 6D9 transition state complex superimpose with r.m.s. differences of 0.29 A Ê and 0.57 A Ê for the variable and constant domains, respectively, including all C a coordinates in calculations with the program LSQMAN (Kleywegt & Jones, 1994) , and show overall similarity to other known antibody structures ( Figure 2 in both models. The electron density for the constant domain loop region, ranging from H128 to H134, is notably poor in the otherwise high quality maps. This results in small real space correlation coef®cients in the corresponding region between the two crystal structures (Figure 4) . The poor density and the high thermal parameters of these surface residues have been noted in other studies (Arevalo et al., 1994; Golinelli-Pimpaneau et al., 1994; Stan®eld et al., 1990; Tulip et al., 1992 ). An analysis with the program PROCHECK (Laskowski et al., 1993) revealed that the overall stereochemical quality of the model from form I was similar to that of other protein structures solved at the same resolution. The main-chain geometries of 86.5 of the residues occupied the``most favored'' regions in the Ramachandran plot. One of the three peptide units (Val L51 ) with``disallowed'' values for the f, c angles has been seen to assume a non-standard conformation in other structures (Arevalo et al., 1994) . In addition, the hydrogen bond energies, the bad contacts in terms of non-bonded interactions, and the side-chain geometries were either better than or close to the average obtained from other structure determinations.
The structural quality of the model from form II, as judged by the PROCHECK routines, was marginally better than the model derived from the form I crystal. The electron density and the temperature factor distribution con®rmed the high¯exibility or disorder of the constant domain region, H128 to H134, but in general, the re®ned model allows the detailed Figure 2 . Cartoon of the overall Fab 6D9 structure. Although similar to other known immunoglobulins, some details of the b-strand associations differ from the standard textbook image (Branden & Tooze, 1991) . Furthermore, it should be noted that the structure contains well-de®ned helical segments. The CPD hapten is shown at the tip of the molecule. Table 1 .
The binding pocket
The hapten binds with high complementarity to an indentation in the surface of the antigen combining site, as often found in antibodies binding haptens of similar size (Padlan, 1994; Figure 6 ). The cavity has the character of a pocket, rather than a long groove which would be expected if the transition state analog bound in an extended conformation. Thus, the folded binding mode of the hapten, which allows stacking interactions between the two aromatic rings of the hapten molecule, is congruent with the shape of the binding site. A comparison with B-DNA revealed that the approximate distance of 4.0 A Ê between these aromatic components, in addition to their precise geometric arrangement, is at least as favorable for such interactions as in the case of DNA nucleotide bases. The hapten is oriented with the stacked aromatic rings at the center of the pocket, the tri¯uoroacetyl portion at the bottom, and the tetrahedral phosphonate moiety exposed towards the solvent. The N-(2-hydroxyethyl)dichloroacetamide portion of the hapten is close to the surrounding water at the tip of the combining site. For immunization, the hapten 3 was coupled via a linker to the carrier protein through the oxygen O 2 , which lies at the cleft entrance, thereby indicating that the hapten molecule itself served as the primary epitope.
The antigen-antibody interactions
The antibody 6D9 generates energy for hapten recognition through a combination of hydrophobic, electrostatic, and hydrogen-bonding interactions. The two stacked aromatic rings of the hapten form the center of a hydrophobic core in the liganded combining site (Figure 7 ). These aromatic rings appear to be associated with Trp H100I and Tyr H58 , presumably through aromatic-aromatic interaction, as revealed from the orientation of the hapten aromtaic rings perpendicular to the two aromatic side chains of the antibody (Burley & Petsko, 1985) . In addition to the perpendicular aromatic interactions, a p-stacking interaction between His H97 and the p-nitrophenyl group of the hapten was observed. Thus, the aromatic interaction among the ®ve aromatic rings appears to be important for the hapten binding. Furthermore form a hydrophobic environment at the bottom of the binding pocket. In this region, the haptenic nitro group appears to contact the protein only by van der Waals interactions, and not through hydrogen bonding. The light chain CDR2, which is outside the combining site, and the heavy chain CDR1 loops provide no residues contributing to the antigenantibody interaction. In contrast, residues from the remaining four CDRs are involved in binding pocket formation. The light chain CDR1 has three residues facing the catalytic cavity: Ser L27E , Asn L28 , and the important His L27D . The light chain CDR 3 includes two residues, Phe L89 and Gly
L91
, playing important roles in the hapten recognition. A signi®cant dipole-induced interaction exists between the carbon-¯uorine bond of the hapten and the side-chain of Phe L89 , which is at a distance of less than 4.0 A Ê . from the halogen atom. The main-chain carbonyl oxygen of Gly L91 and the side-chain of Trp H100I form the hydrogen bond, which is important to ®x the position of H3. The heavy-chain CDR H2 provides Ser H50 , which participates in a hydrogen bond to the oxygen O 8 of the bound hapten, and Tyr
H58
, which is a component of the haptencentered aromatic-aromatic interaction. The heavy chain CDR3 loop embraces the transition state analog and is essential to de®ne the antigen binding pocket. The main-chain nitrogen atom of Gly H100 and the N e atom of His H97 are involved in hydrogen bonding to the carbonyl group of the dichloroacetamide group.
The distribution of ordered solvent molecules around the Fab molecule follows the pattern generally observed in other proteins. Interestingly, no Figure 4 . Plots of the real space correlation coef®cient versus the sequence position for the main-chain (upper) and side-chain atoms (lower). The data reveal that the heavy chain region H128 to H134 is disordered in both models of the Fab 6D9-CPD complex.
internal hydration was observed around the bound transition state analog in the active site of 6D9; water molecules seem to be excluded rather than included in the hapten binding, in contrast to the situation recently reported for anti-sweetener Fab complex (Guddat et al., 1994) .
The dissociation and inhibition constants for the haptenic phosphonates, 3 and 4
In the present crystallographic study, the compound 4 was bound to the active site of the antibody 6D9. Although the compound 4 is a derivative of the original hapten 3, the complex of the Fab 6D9 with 4 allowed us to determine the crystal structure at high resolution. Our structural results show that the structural modi®cation introduced at the phosphonate moiety of the hapten extends as an appendage into the solvent region, and that it is not involved in antibody-ligand binding interactions (Figures 6 and 7 (upper) ). To support this observation, we have examined the binding af®nity of the haptens 3 and 4 and the inhibition patterns during the catalysis, since other studies of antibody-ligand complexes have shown that even small structural alterations in the binding pattern can seriously affect the binding af®nity (Chacko et al., 1995) . Dissociation constants for the binding of the two haptens 3 and 4 to the Fab 6D9 have been determined by¯uorescence titration, Figure 5 . View of the 2F o À F c electron density map (contoured at a 1.0s level) in the hapten binding region. The map was calculated based on the data obtained from form I crystal and the re®ned model. In a different orientation, the density shows clear invaginations at the center of the aromatic functionalities of the hapten, illustrating that its position is de®ned accurately. c A random set of re¯ections, representing ten (form I) and ®ve (form II) % of the initial data, was excluded from the model re®nement. All data were measured with an average six to sevenfold redundancy, which is normally not achieved in monoclinic space groups.
which provided K d values of 13(AE6) and 19(AE2) nM, respectively. The practically identical K d values suggest that the alteration between 3 and 4 does not effect the binding af®nity in the 6D9-ligand interaction. In addition, both haptens showed similar inhibition patterns during the antibody-catalyzed hydrolysis. An analysis with the Dixon plots displayed competitive inhibition, providing K i values of 60(AE6) and 50(AE9) nM for haptens 3 and 4, respectively. Thus, it is anticipated that the presence of the substituent at the oxygen position O 5 will have no effect on our mechanistic interpretation.
Discussion
Structural studies of hydrolytic catalytic antibodies have revealed antigen-combining sites, in which a couple of catalytic functions work in concert (Wedemayer et al., 1997; Charbonnier et al., 1995 Charbonnier et al., , 1997 Patten et al., 1996) . For example, antibody 17E8 catalyzes the hydrolysis by a concerted mechanism of transition-state stabilization with a Lys and nucleophilic catalysis with a Ser-His dyad in the antigen-combining site, as revealed from the X-ray crystal structure (Zhou et al., 1994) and kinetic studies . This proposal seems to be consistent with the transition state analysis of 17E8, in which the rate acceleration factor (k cat /k uncat 8900) deviated from the af®nity ratio (K m /K i 430). Our structural studies of 6D9 also identi®ed an important histidine involved in transition state stabilization in the antigen-combining site. However, there are no catalytic residues, other than the histidine, around the phosphonate moiety of the hapten, as evidenced with the transition state analysis (k cat /k uncat 895, K S / K TSA 900). Consequently, the structural data, together with the previous kinetic study, facilitate simple discussions of the structural basis of transition state stabilization in antibody catalysis.
As shown in the X-ray structure of 6D9 (Figure 7) , a side-chain (N e ) of His L27D is placed in a key position to make a hydrogen bond to the phosphonate oxygen of the transition state analog with a distance of 2.72 A Ê . With the exception of His L27D , a tyrosine, Tyr H58 , appears to be relatively near the phosphonate of the hapten. However, the hydroxyl group would be too remote to serve as a catalytic residue for a nucleophilic attack, even with the proviso of side-chain movement, in addition, there are no residues which activate the hydroxyl group. Thus, no protein functional group appears to be appropriately placed to act as a potent nucleophile. Given the lack of a nucleophile in the active site, water or hydroxide ions are the obvious choice to attack the substrate. Consequently, these observations lend support to the idea that the catalytic activity is mediated through transition state stabilization, by hydrogen bonding of the histidine side-chain to the tethrahedral transition state. The structual data are well consistent with the mutagenesis (Miyashita et al., 1997) . Mutation of Tyr H58 to phenylalanine did not essentially affect the hydrolytic activity as compared to that of the native 6D9, while the alanine mutant of His L27D lost the activity completely. On the other hand, an alternative possibility for the role of the histidine is to act as a nucleophilic or general-base catalyst. This has been proposed by Lerner and coworkers in their study of the esterolytic antibody (6D4), which also possessed a crucial histidine residue, that participated in either nucleophilic or general base catalysis, with the prevailing pathway determined by the choice of substrates (Tramontano et al., 1986) . However, the kinetic studies of antibody 6D9 rule out the possibility of the histidine functioning as a nucleophilic or generalbase catalyst; the antibody-catalyzed hydrolysis proceeds with a ®rst-order dependence on hydroxide ions (log k cat plotted against pH) and without either burst kinetics or noticeable reaction inhibition .
Theoretical and crystallographic studies of thermolysin in complex with various inhibitors have provided an estimate of 4.0 kilocalories per mole 
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for the intrinsic binding energy contained in the speci®c hydrogen binding interaction between an amide NH and a charged oxygen of a phosphoamidate transition state inhibitor (Bartlett & Marlowe, 1987; Bash et al., 1987; Tronrud et al., 1987) . In 6D9, the difference (ÁÁG) in free energy between the antibody-catalyzed and uncatalyzed (background) reactions and the difference (ÁÁG) in the binding energy between the transition state and the ground state were calculated, based on the values of k cat /k uncat and K S /K TSA , respectively, to be 4.0 kilocalories per mole for both . From the X-ray structure, the side-chain of His L27D was found to play an important role for stabilization of the tetrahedral transition state. However, the hydrogen bond of His L27D to the tetrahedral transition state may not be suf®cient to account for the catalytic properties of this immunoglobulin catalyst. Since His L27D is at the tip of the antigen-combining site, a binding energy of the hydrogen bond is likely to be less than 4.0 kilocalories per mole. In addition to His L27D , the aromatic-aromatic interaction with Trp H100I and Tyr H58 also contributes to the transition-state stabilization. In the antibody-hapten complex, the hapten bears a folded comformation and the two stacked aromatic rings are buried deep in the antigen-combining site through the aromatic-aromatic interaction. The conformation of the bound hapten suggests that the antibody binds the substrate to change the conformation of the ester moiety to the thermodynamically unstable E-form, thereby making it easy for the substrate to reach the transitionstate during catalysis: It is well known that esters are planar and that the E-form is much more unstable than the Z-form (Deslongchamps, 1983) . The conformational change of the ester moiety from a stable Z-form to an unstable E-form leads to a weak substrate binding af®nity of the antibody. The transition-state stabilization observed in 6D9-catalyzed hydrolysis is likely due to a pertubation between the intrinsic binding energy to the transition state and the weak binding to the substate (Fersht, 1985) . These observations reveal that the catalytic mechanism is explained purely on the basis of the stabilization of the transition state.
The structural reasons for the substrate speci®city of the antibody 6D9 can readily be understood from the detailed image of the combining site obtained from the structure determinations. Replacement of the nitro group with a dichloroacetamido substituent resulted in a substrate that was not processed by 6D9. The crystal structure shows that this modi®cation cannot be accommodated, due to steric con¯ict with the binding pocket. Changes of the appendage at C 4 of the substrate can be tolerated, in agreement with the solvent exposed position seen in the crystal structures. As mentioned above, an interesting outcome of this structural study is the discovery of the folded hapten conformation and the binding of both the N-triuoroacetylaminophenyl and p-nitrophenyl groups in the hydrophobic environment at the bottom of the active site cavity. A previously reported molecular modeling successfully predicted the antigencombing site structure, but not the bound-hapten conformation, which was assumed to be extended, rather than compactly folded . The fact that the two stacked benzene rings are entirely buried in the antigen-combining cavity, and neither the¯uorine atoms nor the nitro group is hydrogen bonded, provides a rationale as to why the 6D9 catalyst is not severely limited by product inhibition. Thus, the folded state of the two benzene rings is the important epitope. Each product of the mono benzene derivative would no longer possess suf®cient binding af®nity to cause product inhibition.
Recently, structural models of hydrolytic antibodies, which were independently derived from different mice and different haptens, have been reviewed. It was noted that a common structural motif was induced to achieve a catalytic advantage when the immune system was stimulated by immunization with antigens containing aryl phosphonate groups (MacBeath & Hilvert, 1996) . In contrast to their proposal, the antibody 6D9 shows a different catalytic structure of the antigen-combining site, despite the fact that the antibody was also elicited against an aryl phosphonate antigen. As compared with the other antibodies, 6D9 possesses a light chain CDR1 (16 amino acids) and a heavy chain CDR3 (14 amino acids) with longer amino acid sequences , which result in an antigen-combining site with a cavity opened relatively wide; for example, CNJ 206 possesses the LCDR1 of 11 amino acids and the HCDR3 of 10 amino acids. The antigen binding of 6D9 is dominated by amino acid residues within the extended loop structures of the two CDRs. Especially, in comparison with the other hydrolytic antibodies, the structure of the antigen-combining site is characterized by the potential to bind the two stacked aromatic rings of the ligand, which additionally contributes to the transition-state stabilization as mentioned above. Since the hapten used in this study shares some of the unique features of other haptens used for catalytic antibodies, the re®ned high resolution structures reported here are envisaged to have an impact on the understanding of other hydrolytic antibodies. Furthermore, the structural information is useful for understanding a single process of transition-state stabilization in enzyme catalysis on a structural basis, as well as for increasing catalytic ef®ciency by site-directed mutagenesis and for designing a new hapten that induces catalytic antibodies with higher activity.
Materials and Methods
Data collection
The two different crystal forms of the 6D9 Fab fragment complexed with a transition state analog have been characterized in this study. The details of crystallization and the data collection have been described (Kristensen et al., 1995) .
X-ray diffraction data were collected from two form I crystals, using both a conventional X-ray source (a MacScience M18X rotaing anode generator equipped with a DIP100 imaging plate system) and synchrotron radiation (beam line BL6A2, Photon Factory, Tsukuba). The WEIS data processing software packages were used to integrate the intensities (Higashi, 1989) . The data were merged and scaled by means of the program PROTEIN (Steigemann, 1974) . Diffraction data from two form II crystals were recorded exclusively using synchrotron radiation and the Weissenberg camera installed at the Photon Factory. The data were processed by the programs DENZO and SCALEPACK (Otwinowski, 1993) .
Structure determination and refinement
The peptide binding antibody B13I2 (Stan®eld et al., 1990) , which speci®cally binds a synthetic homolog of the C-helix of myohemerythrin, was used as a search model in the molecular replacement solution of the Fab 6D9-hapten complex. Both antibodies, 6D9 and B13I2, belong to the same isotypic subgroup (IgG1, kappa light chain), and the overall sequence identity is 92.4%.
The structure determination was ®rst carried out based on the form I data. Since the crystals contained only one Fab molecule in the asymmetric unit, it was anticipated that an intact Fab model (four domains) would provide a reasonable starting point for the calculations. The peptide antigen, as well as the N-acetyl-Dglucosamine modi®cation of an asparagine residue, was omitted from the coordinate ®le deposited in the Brookhaven Protein Data Bank (entry-code: 2igf). At this stage, no attempts were made to correct for the differences in the sequences of the two antibodies. The program package X-PLOR was used for the molecular replacement (MR) calculations, as well as for the re®nement (Bru È nger, 1992) .
Rotation functions evaluated data between 8.0 and 3.5 A Ê and restricted model Patterson vectors (4 to 24 A Ê in length) yielded a cross-rotation map with enough features to recognize the correct solution. The orientations of the model, indicated by the list of peaks, were optimized and tested by adjustment of the relative positions of the four Fab domains (V L , V H, C L , and C H 1) by the rigid body re®nement procedure. The top three peaks represented practically the same orientation. However, only the third peak was suf®ciently precise to permit a stable re®nement. The validity of this orientation was con®rmed by Patterson correlation re®nement (Bru È nger, 1990) , which provided the Euler angles y 1 , y 2 , y 3 ( 25.302, 74.000, 28.635 ) to be applied for the rotational component. With the 8.0 to 3.5 A Ê resolution data, a search revealed the correct position of the model to be indicated by the single strong peak in the translation function, which in fractional coordinates was determined as x, y, z (0.463, 0.0, 0.160). The four domains of this positioned model were then allowed to move as independent units in rigid body re®nement. The crystallographic R value at this stage was 41.5% for data between 6.0 and 3.0 A Ê . The 2F o À F c map, calculated after conjugate gradient minimization and re®nement of the model by simulated annealing (SA) using the slowcooling protocol, showed clear electron density for the major part of the molecule. From a global viewpoint, the complementarity determining regions of the variable domain were de®nable, except for the H3 loop. Although relatively abundant, the electron density in this region was unconnected. Using the``mutate option'' in the program O (Jones et al., 1991) , the non-cognate residues of the model were changed to ®t the sequence of the Fab 6D9, and the necessary insertions and deletions were introduced. Multiple cycles of X-PLOR re®nement (Powell minimization and SA), combined with rebuilding of the model with O, did not signi®cantly improve the density for the important CDR H3 region. The calculation of the F o À F c omit maps provided insuf®cient information to facilitate real progress. After unrestrained re®nement of the grouped temperature factors (B-factors), the crystallographic R value came to rest at 24% for the data between 6.0 and 2.0 A Ê . An electron density map, calculated based on a solvent¯attening procedure with restrained phases (Wang, 1985) , improved the situation dramatically and made it a tangible task to trace the H3 loop. The density for the hapten in the antibody-combining site was clearly seen to reside in the vicinity of the prominent CDR H3. After several cycles of re®nement, including manual adjustment, SA at 4000 K, and restrained individual B factors, 140 water molecules were sequentially added to the model, using the CCP4 program WATERPEAKS (SERC, 1979) and the``pekpik option'' in O. The ®nal R value is 19.8 % for the data between 6.0 and 1.8 A Ê . A decreasing free R value con®rmed the progress of the model (Bru È nger, 1990 ). The ®nal model agrees with the data (6.0 to 1.8 A Ê ) to produce a free R value of 28.2 %.
The structure of the Fab 6D9 transition state complex, as crystallized in the second crystal form, form II, was solved generally as described above, with the use of the re®ned coordinates of the form I model. One cycle of re®nement with the X-PLOR simulated annealing protocol resulted in an R value of 26.4 % for the 6.0 to 2.5 A Ê data. The re®ned structure includes 217 water molecules and represents a model with an R value of 22.8 % for data between 6.0 and 1.8 A Ê . The free R value is 29. 5% .
The approximately 2-fold related units of the Fab (V L / V H and C L /C H ) were superimposed to optimize the ®t using the program LSQMAN (Kleywegt & Jones, 1994) . The following residues were used: V L : 1 to 23, 35 to 48, 61 to 87, and 98 to 107; V H : 1 to 22, 36 to 49, 66 to 91, and 103 to 112; C L : 109 to 117, 129 to 142, 144 to 149, 158 to 162, 170 to 186, and 192 to 198; C H : 119 to 127, 139 to 152, 154 to 159, 166 to 170, 172 to 193, and 198 to 204. From the direction cosines of the rotation axis, as determined by the program, the elbow angle was calculated using the formula: cos y cos a 1 cos a 2 cos b 1 cos b 2 cos g 1 cos g 2 . The programs Molscript (Kraulis, 1991) and Raster3D (Merritt & Murphy, 1994) were used in the Figure preparations. Atomic coordinates for both crystal forms I and II have been deposited at the Brookhaven Data Bank with the entry-codes 1HYX and 1HYY, respectively.
Determination of dissociation and inhibition constants for haptenic phosphonates
Dissociation constants were determined by¯uor-escence titration, with a Hitachi F-4000 spectrophotometer. The formation of hapten complexes of the Fab 6D9 was followed by measuring the tryptophan quenching upon the addition of increasing concentrations of the hapten. The¯uorescence intensity was measured at 340 nm, using an excitation wavelength of 295 nm. To 2.0 ml of 0.03 mM Fab 6D9 in 50 mM Hepes (pH 8.0 ) was added small aliquots of 10 mM hapten in the same buffer at 25 C, and the change (ÁF) of the¯ourescence was determined. .
